SCHEMBL17366289

SCHEMBL17366289

Cc1ccccc1Nc1ncnc(Cl)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.67
LRRK2 Q5S007 1/20 0.56
CCNA2 P20248 4/20 0.48
CDK2 P24941 4/20 0.48
CDK5 Q00535 1/20 0.48
CDK5R1 Q15078 1/20 0.48
CCNK O75909 2/20 0.47
CCND3 P30281 2/20 0.47
CDK9 P50750 2/20 0.47
CDK6 Q00534 2/20 0.47
TSHR P16473 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206101 0.83 TSHR (0.68) HTTTSHRNPC1RAB9ASMN1; SMN2
SCHEMBL10939229 0.82 TSHR (0.67) HTTLRRK2TSHRNPC1RAB9A
SCHEMBL6489892 0.81 RAPGEF4 (0.49) HTTNPC1RAB9AKMT2AKDM4E
SCHEMBL13395050 0.80 AURKA (0.47) HTTCDK2CDK5CDK9TSHR
SCHEMBL9818543 0.80 HTT (0.67) HTTLRRK2CCNA2CDK2CDK5
SCHEMBL2493802 0.80 HTT (1.00) HTTLRRK2CCNA2CDK2CDK5
SCHEMBL6482620 0.79 ULK1 (0.49) HTTTSHRNPC1RAB9ASMN1; SMN2
SCHEMBL10151119 0.78 HTT (0.41) HTTLRRK2TSHRNPC1RAB9A
SCHEMBL13395229 0.77 ALK (0.55) HTTCDK9TSHRNPC1RAB9A
SCHEMBL16803641 0.77 ALK (0.48) CDK9PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2704572-B1 COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS ARIAD PHARMA INC (US) 2015-12-30 EP disclosed